Related Experiment Video
Updated: Jul 9, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
p53-dependent Chk1 phosphorylation is required for maintenance of prolonged G2 Arrest
Xiao Qi Wang1, Eric J Stanbridge, Xiaoyan Lao
1Department of Microbiology and Molecular Genetics, University of California Irvine, School of Medicine, Irvine, California 92697, USA.
Abstract:
Targeting checkpoint kinases has been shown to have a potential chemosensitizing effect in cancer treatment. However, inhibitors of such kinases preferentially abrogate the DNA damage-induced G2 checkpoint in p53-/- as opposed to p53+/+ cells. The mechanisms by which p53 (TP53) can prevent abrogation of the G2 checkpoint are unclear. Using normal human diploid p53+/+ and p53-/- fibroblasts as model systems, we have compared the effects of three checkpoint inhibitors, caffeine, staurosporine and UCN-01, on gamma-radiation-induced G2 arrest. The G2 arrest in p53+/+ cells was abrogated by caffeine, but not by staurosporine and UCN-01, whereas the G2 arrest in p53-/- cells was sensitive to all three inhibitors. Chk2 (CHEK1) phosphorylation was maintained in the presence of all three inhibitors in both p53+/+ and p53-/- cells. Chk1 phosphorylation was maintained only in the presence of staurosporine and UCN-01 in p53+/+ cells. In the presence of caffeine Chk1 phosphorylation was inhibited regardless of p53 status. The pathway of Chk1 phosphorylation --> Cdc25A degradation --> inhibition of cyclin B1/Cdk1 activity --> G2 arrest is accordingly resistant to staurosporine and UCN-01 in p53+/+ cells. Moreover, sustained phosphorylation of Chk1 in the presence of staurosporine and UCN-01 is strongly related to phosphorylation of p53. The present study suggests the unique role of Chk1 in preventing abrogation of the G2 checkpoint in p53+/+ cells.
Insights
Checkpoint kinase inhibitors can sensitize cancer cells to chemotherapy. This study reveals that the protein p53 plays a key role in maintaining the G2 checkpoint, preventing its abrogation by certain inhibitors in p53+/+ cells.
Area of Science:
- Cell cycle regulation
- Cancer therapy
- DNA damage response
Background:
- Checkpoint kinases are targets for cancer therapy, potentially enhancing chemosensitivity.
- Checkpoint kinase inhibitors often disrupt the DNA damage-induced G2 checkpoint more in p53-deficient (p53-/-) than in p53-proficient (p53+/+) cells.
- The precise mechanisms by which p53 prevents G2 checkpoint abrogation remain unclear.
Purpose of the Study:
- To investigate the role of p53 in preventing the abrogation of the gamma-radiation-induced G2 checkpoint by different checkpoint inhibitors.
- To compare the effects of caffeine, staurosporine, and UCN-01 on G2 arrest in p53+/+ and p53-/- human diploid fibroblasts.
Main Methods:
- Utilized normal human diploid p53+/+ and p53-/- fibroblasts as model systems.
- Compared the effects of three checkpoint inhibitors (caffeine, staurosporine, UCN-01) on gamma-radiation-induced G2 arrest.
- Assessed Chk1 and Chk2 phosphorylation status in the presence of inhibitors and varying p53 expression.
Main Results:
- Caffeine abrogated G2 arrest in p53+/+ cells, while staurosporine and UCN-01 did not. All three inhibitors abrogated G2 arrest in p53-/- cells.
- Chk2 phosphorylation was maintained in both cell types with all inhibitors.
- Chk1 phosphorylation was maintained with staurosporine and UCN-01 in p53+/+ cells, but inhibited by caffeine regardless of p53 status.
- The pathway involving Chk1 phosphorylation, Cdc25A degradation, and cyclin B1/Cdk1 inhibition was resistant to staurosporine and UCN-01 in p53+/+ cells.
- Sustained Chk1 phosphorylation in p53+/+ cells treated with staurosporine/UCN-01 correlated with p53 phosphorylation.
Conclusions:
- The study highlights a unique role for Chk1 in maintaining the G2 checkpoint in p53+/+ cells.
- p53 appears to protect the G2 checkpoint from abrogation by specific checkpoint inhibitors.
- These findings contribute to understanding the differential effects of checkpoint inhibitors based on p53 status in cancer therapy.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...

